Cefurim CV Powder for Suspension 70ml

Name: Cefurim CV Powder for Suspension 70ml
Brand: Somatec Pharmaceuticals Ltd.
SKU: 17354
Availability: InStock

Generic: Cefuroxime Axetil + Clavulanic Acid

Manufacturer

Somatec Pharmaceuticals Ltd.

৳ 260

Quick Tips

You have been prescribed Cefurim CV (125 mg+31.25 mg)/5 ml Syrup medicine to treat bacterial infections, even if they have developed resistance.
Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection to come back and harder to treat.
Take it with food to avoid an upset stomach.
Diarrhea may occur as a side effect. Taking probiotics may help. Talk to your doctor if you notice bloody stools or develop abdominal cramps.
Stop taking Cefurim CV (125 mg+31.25 mg)/5 ml Syrup and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking it.
Do not use leftover medicine for treating any infection in the future. Always consult your doctor before taking any antibiotic.

Buy 15 products and get ৳ 20 discount

0 people are viewing this right now

Estimated Delivery : Up to 4 business days

Category: Prescription Medicine Brand: Somatec Pharmaceuticals Ltd.

Description
Reviews (0)

Description

Indications

Cefurim CV is indicated for the treatment of infections caused by sensitive bacteria.

Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.
Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.
Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains)
Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli.
Acute bacterial exacerbation of chronic bronchitis and secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains).
Uncomplicated skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes.
Uncomplicated urinary tract infections caused by E.coli or Klebsiella pneumoniae.
Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).
Uncomplicated Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae.
Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi.
Septicemia caused by Staphylococcus aureus, Streptococcus pneumoniae, E.coli, Haemophilus influenzae (including ampicillin-resistant strains) & Klebsiella spp.
Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Neisseria meningitidis & Staphylococcus aureus (penicillinase and non-penicillinase producing strains)
Switch therapy (Injectable to oral)
Pharmacology

Cefuroxime is a bactericidal second generation cephalosporin antibiotic which is active against a wide range of Gram-positive and Gram-negative susceptible organisms including many beta-lactamase producing strains. Cefuroxime inhibits bacterial cell wall synthesis by interfering with the transpeptidation process.

Clavulanic acid is a naturally derived beta lactamase inhibitor produced by Streptomyces clavuligerus. It has similar structure to beta lactam antibiotics which binds irreversibly to beta-lactamase enzymes and inactivates them. Clavulanic acid gives protection of Cefuroxime from degradation by beta lactamase enzymes and provides a solution for the treatment of bacterial infections caused by beta lactam resistant bacteria.
Dosage & Administration
Adolescents and adults (13 years and older)-
- Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days
- Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days
- Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days
- Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days
- Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days
- Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days
- Uncomplicated Gonorrhoea: 1000 mg b.i.d. Single dose
- Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days
- MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days
- Early Lyme disease: 500 mg b.i.d. for 20 days
Paediatric Patients (3 months to 12 years)-
- Pharyngitis/Tonsillitis: 20 mg/kg/day b.i.d for 5-10 days
- Acute otitis media: 30 mg/kg/day b.i.d for 10 days
- Acute bacterial maxillary sinusitis: 30 mg/kg/day b.i.d for 10 days
- Impetigo: 30 mg/kg/day b.i.d for 10 days
Cefuroxime-Clavulanic Acid tablet may be taken without regard of food.
Interaction

Concomitant administration of probenecid with Cefuroxime-Clavulanic Acid increases the area under the serum concentration versus time curve by 50%. Drug that reduces gastric acidity may result in a lower bioavailability of Cefuroxime and tend to cancel the effect of postprandial absorption.
Contraindications

Cefuroxime-Clavulanic Acid is contraindicated in patients with known allergy to cephalosporin & in patients with Pseudomembranous Colitis.

Side Effects

Generally Cefuroxime-Clavulanic Acid is well tolerated. However, a few side effects like nausea, vomiting, diarrhea, abdominal discomfort or pain may occur. As with other broad-spectrum antibiotics, prolonged administration of Cefuroxime and Clavulanic acid combination may result in overgrowth of nonsusceptible microorganisms. Rarely (<0.2%) renal dysfunction, anaphylaxis, angioedema, pruritis, rash and serum sickness like urticaria may appear.

Pregnancy & Lactation

While all antibiotics should be avoided in the first trimester if possible. However, Cefuroxime-Clavulanic Acid can be safely used in later pregnancy to treat urinary and other infections. Cefuroxime-Clavulanic Acid is excreted into the breast milk in small quantities. However, the possibility of sensitizing the infant should be kept in mind.

Precautions & Warnings

Cefuroxime should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis.

Storage Conditions

Store in a cool, dry place (below 30^o C), away from light and moisture. Keep out of the reach of children.
Common Questions about Cefurim CV (125 mg+31.25 mg)/5 ml Suspension

What is Cefurim CV (125 mg+31.25 mg)/5 ml Syrup?

Cefuroxime is the cephalosporin antibiotic and Clavulanic acid is a beta-lactamase inhibitor. Cefurim CV (125 mg+31.25 mg)/5 ml Syrup is indicated for the treatment of infections caused by sensitive bacteria.

What is Cefurim CV (125 mg+31.25 mg)/5 ml Syrup used for?

Cefurim CV (125 mg+31.25 mg)/5 ml Syrup is used to treat pharyngitis, tonsillitis, sinusitis, bronchitis, SSTI, UTI, gonorrhoea, pneumonia, typhoid fever.

How long does it take for Cefurim CV (125 mg+31.25 mg)/5 ml Syrup to take effect?

Cefurim CV (125 mg+31.25 mg)/5 ml Syrup starts working within 2-3 hours after taking it.

How long do the effects of this medicine last?

The effect of Cefurim CV (125 mg+31.25 mg)/5 ml Syrup lasts for an average duration of 4-8 hours.

Cefurim CV (125 mg+31.25 mg)/5 ml Syrup it safe to consume alcohol while taking this medicine?

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Is Cefurim CV (125 mg+31.25 mg)/5 ml Syrup a habit forming medicine?

No habit-forming tendencies were reported for Cefurim CV (125 mg+31.25 mg)/5 ml Syrup.

Can this medicine be taken during pregnancy?

Cefurim CV (125 mg+31.25 mg)/5 ml Syrup is safe to use in pregnancy to treat bacterial infections. However, it is recommended to use this medicine only after consulting your doctor.

Can Cefurim CV (125 mg+31.25 mg)/5 ml Syrup be taken while breast-feeding?

Cefurim CV (125 mg+31.25 mg)/5 ml Syrup is safe to use during breastfeeding. It enters into breast milk at low levels.

Quick Tips

You have been prescribed Cefurim CV (125 mg+31.25 mg)/5 ml Syrup medicine to treat bacterial infections, even if they have developed resistance.

Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection to come back and harder to treat.

Take it with food to avoid an upset stomach.

Diarrhea may occur as a side effect. Taking probiotics may help. Talk to your doctor if you notice bloody stools or develop abdominal cramps.

Stop taking Cefurim CV (125 mg+31.25 mg)/5 ml Syrup and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking it.

Do not use leftover medicine for treating any infection in the future. Always consult your doctor before taking any antibiotic.

Reviews

There are no reviews yet.

Be the first to review “Cefurim CV Powder for Suspension 70ml”

Cefurim CV Powder for Suspension 70ml

Quick Tips

Buy 15 products and get ৳ 20 discount

Description

Indications

Pharmacology

Dosage & Administration

Interaction

Contraindications

Side Effects

Pregnancy & Lactation

Precautions & Warnings

Storage Conditions

Common Questions about Cefurim CV (125 mg+31.25 mg)/5 ml Suspension

What is Cefurim CV (125 mg+31.25 mg)/5 ml Syrup?

What is Cefurim CV (125 mg+31.25 mg)/5 ml Syrup used for?

How long does it take for Cefurim CV (125 mg+31.25 mg)/5 ml Syrup to take effect?

How long do the effects of this medicine last?

Cefurim CV (125 mg+31.25 mg)/5 ml Syrup it safe to consume alcohol while taking this medicine?

Is Cefurim CV (125 mg+31.25 mg)/5 ml Syrup a habit forming medicine?

Can this medicine be taken during pregnancy?

Can Cefurim CV (125 mg+31.25 mg)/5 ml Syrup be taken while breast-feeding?

Quick Tips

Reviews

Related products

Galvus Met50 mg+500 mg

Rosuva10 mg

Ecosprin75 mg

Comet500 mg